Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Titagen® improves skin, hair, nail health, and reduces osteoarthritis symptoms safely.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

The new formulation improved the skin absorption of the drug Thiocolchicoside.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

The tool kit helps transit agencies ensure safety by managing employees' medication use.

A new compound shows promise as a topical treatment for hair loss.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Cedrol may help treat inflammatory bowel disease by improving gut health and function.

Injecting 2 ml of TEEV every 4 weeks is better because it has the same benefits but fewer side effects.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Cedrol-loaded microneedles effectively promote hair growth.

The new hair treatment significantly reduces hair shedding safely.

The treatment effectively reduces menopausal symptoms and is well tolerated.

The method effectively detects MeT and TP in dried blood spots after cream application.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Toluene diisocyanate exposure can cause immune sensitization by interacting with proteins in hair follicles and sebaceous glands.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Improving PROTAC delivery systems can enhance their effectiveness and speed up their use in medicine.